United States Últimas notícias

In an exclusive conversation with Bloomberg's Heesu Lee, South Korean budget minister Park Hong Keun says that the fund financed by semiconductor-driven tax gains will serve as a fiscal dam to cushion from higher yields

Lakeland Financial Corporation (NASDAQ:LKFN) reported record third-quarter 2026 net income of $28.9 million, an increase of 9% from $26.4 million a year earlier, while diluted earnings per share rose 11% to $1.14.

Sierra Bancorp (NASDAQ:BSRR) reported record third-quarter 2026 net income of $15.3 million, a 58% increase from $9.7 million a year earlier, while diluted earnings per share climbed 64% to $1.18 from $0.72.

S&P Global (NYSE:SPGI) has completed its acquisition of blockchain security company OpenZeppelin, expanding its digital asset risk assessment capabilities to cover the technology underlying tokenized financial products and decentralized finance.

"Right now, the bond side of things, the rate side of things, is probably the easier trade to be in," says Max Kettner, chief multi-asset strategist at HSBC Bank. He explains the factors behind his cautious view of equities through the end of the year amid what he calls "narrative bingo." He speaks on "Bloomberg Surveillance."

Regeneron Pharmaceuticals (NASDAQ:REGN) announced a $270 million extension of its agreement with the Biomedical Advanced Research and Development Authority to supply additional doses of Inmazeb for U.S. preparedness against Ebola outbreaks.

Fate Therapeutics (NASDAQ:FATE) presented preliminary Phase 1 clinical results for FT819 showing renal responses in two evaluable patients with lupus nephritis, a serious kidney complication of systemic lupus erythematosus.

CAE (NASDAQ:CAE) has signed a definitive agreement to sell Flightscape, its airline operations software business, to aviation technology provider SITA for an enterprise value of US$500 million.

City Holding Company (NASDAQ:CHCO) reported third-quarter 2026 net income of $34.6 million and record diluted earnings of $2.43 per share, compared with $33.3 million and $2.35 per share in the second quarter.

Acumen Pharmaceuticals (NASDAQ:ABOS) reported a third-quarter 2026 net loss of $25.4 million, compared with $26.5 million a year earlier, as the biotechnology company prepares to release Phase 2 Alzheimer's disease trial results in November.

Nur Cristiani, head of Latin America investment strategy at JPMorgan Private Bank, examines the market implications of the Brazilian election after President Luiz Inácio Lula da Silva pulled off a stunning comeback to defeat Flávio Bolsonaro, the right-wing candidate that many investors preferred. She speaks on "Bloomberg Surveillance."

Verizon Communications (NYSE:VZ) reported third-quarter 2026 revenue of $34.3 billion, an increase of 1.5% year over year, while consolidated net income rose 5.2% to $5.3 billion and earnings per share increased 6.8% to $1.25.